Table 2.
Variables | Class 1 (n = 75) |
Class 2 (n = 142) |
Class 3 (n = 51) |
Class 4 (n = 264) |
P Value |
---|---|---|---|---|---|
Age, yb | 41.2 ± 14.5 | 43.3 ± 16.8 | 48.4 ± 17.3 | 46.4 ± 16.9 | .029 |
Sex | |||||
Female | 49 (65.3) | 85 (59.9) | 26 (51.0) | 136 (51.5) | .105 |
Male | 26 (34.7) | 57 (40.1) | 25 (49.0) | 128 (48.5) | |
Cyst type | |||||
Intraparenchymal | 75 (100.0) | 131 (92.3) | 35 (68.6) | 145 (54.9) | <.001 |
Extraparenchymal | 0 (0.0) | 11 (7.7) | 16 (31.4) | 119 (45.1) | |
Cyst stagec | |||||
Nonviable | 69 (92.0) | 73 (55.7) | 7 (20.0) | 27 (18.6) | <.001 |
Viable | 6 (8.0) | 58 (44.3) | 28 (80.0) | 118 (81.4) | |
Cyst burdend, median (IQR) | 1e | 1 (2) | 3 (3.5) | 3 (9) | <.001 |
Data are presented as No. (%) unless otherwise indicated.
Abbreviation: IQR, interquartile range.
aClasses: 1 (negative or positive to antigens of the GP50 protein family); 2 (positive to antigens of the protein T24-42 protein family, with or without GP50); 3 (positive to antigens of the GP50, T24-42, and 8 kDa protein families); and 4 (positive to antigens of the GP50 and T24-42 protein families and strongly positive to antigens of the 8 kDa protein family).
bMean ± standard deviation.
cEvaluated in intraparenchymal neurocysticercosis (NCC) cases only.
dEvaluated in intraparenchymal NCC cases with viable cysts only.
eSingle viable cysts only were observed.